US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Tevogen Bio Holdings Inc.

0.0423

0.0000

Post-market: 0.0355-0.0068-16.08%17:52 EST

Volume:6.67K

Turnover:250.64

Market Cap:8.32M

PE:-0.20

High:0.0423

Open:0.0374

Low:0.0373

Close:0.0423

52wk High:0.0891

52wk Low:0.0301

Shares:196.71M

Float Shares:196.71M

Volume Ratio:0.04

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.2138

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Tevogen Bio Holdings Inc.

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://semperparatusspac.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Tevogen Bio Holdings Inc. operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients. It is also developing TVGN 601 for treating multiple sclerosis; TVGN 930 for the treatment of Epstein-Barr virus associated lymphomas; TVGN 920 for treating cervical cancer; and TVGN 960 for the treatment of mouth and throat cancer. The company was founded in 2020 and is headquartered in Warren, New Jersey.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TVGNW/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TVGNW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGNW\",,,,,undefined,":{"symbol":"TVGNW","market":"US","secType":"STK","nameCN":"Tevogen Bio Holdings Inc.","latestPrice":0.0423,"timestamp":1771016400000,"preClose":0.0423,"halted":0,"volume":6668,"hourTrading":{"tag":"盘后","latestPrice":0.0355,"preClose":0.0423,"latestTime":"17:52 EST","volume":100,"amount":3.55,"timestamp":1771023138633,"change":-0.0068,"changeRate":-0.160757,"amplitude":0},"delay":0,"changeRate":0,"floatShares":196705066,"shares":196705066,"eps":-0.2138,"marketStatus":"Market Closed","change":0,"latestTime":"02-13 16:00:00 EST","open":0.0374,"high":0.0423,"low":0.0373,"amount":250.6444,"amplitude":0.118203,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.2138,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0423,"postHourTrading":{"tag":"盘后","latestPrice":0.0355,"preClose":0.0423,"latestTime":"17:52 EST","volume":100,"amount":3.55,"timestamp":1771023138633,"change":-0.0068,"changeRate":-0.160757,"amplitude":0},"volumeRatio":0.043067462178716445},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGNW\",,,,,undefined,":{"symbol":"TVGNW","floatShares":196705066,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.043067462178716445,"shares":196705066,"dividePrice":0,"high":0.0423,"amplitude":0.118203,"preClose":0.0423,"low":0.0373,"week52Low":0.03011,"pbRate":"--","week52High":0.0891,"institutionHeld":0,"latestPrice":0.0423,"eps":-0.2138,"divideRate":0,"volume":6668,"delay":0,"ttmEps":-0.2138,"open":0.0374,"prevYearClose":0.0422,"prevWeekClose":0.0432,"prevMonthClose":0.0425,"prevQuarterClose":0.0422,"fiveDayClose":0.0432,"twentyDayClose":0.0467,"sixtyDayClose":0.0451},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TVGNW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-02-15","symbol":"TVGNW","reason":null,"defaultRemindTime":1708007400000,"announcedDate":"2024-02-14","type":"delisting","dateTimestamp":1707973200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TVGNW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TVGNW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://semperparatusspac.com","stockEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":-0.0516},{"period":"3month","weight":-0.0621},{"period":"6month","weight":-0.295},{"period":"1year","weight":-0.4666},{"period":"ytd","weight":0.0024}],"compareEarnings":[{"period":"1week","weight":-0.0128},{"period":"1month","weight":-0.0125},{"period":"3month","weight":0.0146},{"period":"6month","weight":0.0595},{"period":"1year","weight":0.1181},{"period":"ytd","weight":-0.0002}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Tevogen Bio Holdings Inc. operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients. It is also developing TVGN 601 for treating multiple sclerosis; TVGN 930 for the treatment of Epstein-Barr virus associated lymphomas; TVGN 920 for treating cervical cancer; and TVGN 960 for the treatment of mouth and throat cancer. The company was founded in 2020 and is headquartered in Warren, New Jersey.","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":1.185666},{"month":2,"riseRate":0.2,"avgChangeRate":0.165693},{"month":3,"riseRate":0.5,"avgChangeRate":-0.000591},{"month":4,"riseRate":0.25,"avgChangeRate":-0.197994},{"month":5,"riseRate":0.25,"avgChangeRate":-0.093258},{"month":6,"riseRate":0.25,"avgChangeRate":-0.057785},{"month":7,"riseRate":0.25,"avgChangeRate":-0.074125},{"month":8,"riseRate":0.25,"avgChangeRate":0.077491},{"month":9,"riseRate":0,"avgChangeRate":-0.211012},{"month":10,"riseRate":0.5,"avgChangeRate":1.37273},{"month":11,"riseRate":0,"avgChangeRate":-0.435766},{"month":12,"riseRate":0.25,"avgChangeRate":0.047247}],"exchange":"NASDAQ","name":"Tevogen Bio Holdings Inc.","nameEN":"Tevogen Bio Holdings Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"TVGNW\",market:\"US\",,,undefined,":null}}